Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Comment by SPCEO1on Jan 15, 2021 8:37pm
231 Views
Post# 32312156

RE:RE:Why did they do this horrible offering?

RE:RE:Why did they do this horrible offering?It traded almost 24,000 shares on a Friday night when it almost never has any trading after hours. Given the very odd situation that developed this week with the offering, I think we should all be paying close attention to what is going on. I know you are not wanting to see any further pressure on the share price but we can't just close our eyes to real things that are happening such as unusual after hours trading Hopefully, it is nothing but an oddity that means nothing. But those unusual trades did happen and the circumstances of the offering were really strange.
1998novl wrote: First of all there is very little after hours activity going on. Not sure why you are highlighting that?

Secondly, and more importantly- why keep speculating about something that is impossible to know, and instead focus on what you do know. Like the next earnings call will be late February and that is a great time to have questions answered. As a large shareholder, surely you could convince an analyst to ask a question on your behalf, or even submit a question to the company yourself!


<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse